You are here: Industry Insights > cholesterol

News List

Anhui Chem-Bright:Description of Featured Foreign Trade Product PharmaSources.com
November 13, 2017
Feed grade cholesterol and medical grade cholesterol sell well in China and foreign countries
FDA approves add-on therapy to lower cholesterol among certain high-risk adults FDA
December 23, 2021
FDA has approved Leqvio (inclisiran) injection as a treatment to be used along with diet and maximally tolerated statin therapy for adults with heterozygous familial hypercholesterolemia (HeFH)...
AHA News: Healthy Hearts and Brains Get Their Start in Childhood drugs
August 17, 2021
High blood pressure, high cholesterol and other risk factors for poor heart and brain health are problems people typically don't think about until they hit midlife.
Statin Users May Have Added Protection Against Severe COVID-19 drugs
July 21, 2021
Could cholesterol-lowering statins help lower your risk of dying from COVID-19?
Common Medication Used to Reduce Cholesterol Levels May Reduce COVID-19 Severity firstwordpharma
July 16, 2021
In a new study from University of California San Diego School of Medicine, researchers have confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19.
For Losing Weight, Calorie Counting Tops Fasting Diets drugs
June 17, 2021
Intermittent fasting diets are all the rage, but new clinical trial results indicate they don't work any better than simple calorie cutting.
Could a Type of Statin Raise Dementia Risks? drugs
June 16, 2021
Certain cholesterol-lowering drugs might speed dementia in some older adults whose memories are starting to fail, a small, preliminary study suggests.
Weight-Loss Surgeries Used Least in U.S. States That Need Them Most drugs
June 15, 2021
The American South and Midwest are home to the highest obesity rates in the nation, but a new study reveals that severely obese residents of those regions are the least likely to choose lifesaving weight-loss surgery.
Merck KGaA boosts lipid capacity to meet vaccine demand cphi-online
May 31, 2021
The company's new synthetic cholesterol product will help meet the demand for mRNA vaccines, including Pfizer-BioNTech Covid-19 Vaccine
Novartis’ cholesterol med Leqvio wins EU approval pharmatimes
December 15, 2020
Swiss pharma company Novartis’ cholesterol-lowering drug Leqvio (inclisiran) has been granted approval from the European Commission (EC) for the treatment of primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidaemia.

Previous page 1 2 3 4 Next page